Zr-89 Crefmirlimab Berdoxam
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Zr-89 Crefmirlimab Berdoxam, covering 2026-02-05 to 2026-02-05. Get the full timeline:
Most recent: Clinical Trial Update: Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors [Phase 1]